From this page You could reach all the figures at the Turkish Journal of Hematology archive.
You could save all the imges by the save as button and paste them to office documents.
Please use the articles details for reference.
You could see the abstracts of the images from the link above the image.
Search In Pictures
Search In Articles
Not null!
Search term(s) must be at least 3 characters!
All Types
Microscope display
FISH display
(MDCT),MRI,radiologic
Dermatologic
Other
11 records found...
First Observation of Hemoglobin M Saskatoon (ß63 (E7) His>Tyr(C-T)) in the Iraqi Population
Figure 1: The patient’s sequencing data showing Hb M Saskatoon.
First observation of hemoglobin Crete [Beta129(H7) Ala>Pro] in the Turkish population
Figure 1. Automatic DNA sequencing data for the Hb Crete patient. Ais the normal sequence, B is the Hb Crete sequence
Two rare hemoglobin variants in the Çukurova Region of Turkey: Hb E-Saskatoon and Hb G-Coushatta
Figure 1. Direct DNA Sequence Analysis of the ß Gene Showing the Sense Strand in the Vicinity of Codon 22 A. Homozygous Hb E-Saskatoon [ß22(B4); AAG›AAA (Glu›Lys)] B. Heterozygous Hb E-Saskatoon C. Heterozygous HbG-Coushatta [ß22 (B4); AAG›ACG (Glu›Ala)]
Hb D-Los Angeles [beta121(GH4)Glu>Gln] and Hb Beograd [beta121(GH4)Glu>Val]: Implications for their laboratory diagnosis and genetic origins
Figure 1. High performance liquid chromatography profile of Hb Beograd
First observation of Hb D-Ouled Rabah [beta19(B1)Asn>Lys] in the Turkish population
Figure 1. HPLC profile of the Hb variant Hb D-Ouled Rabah
First observation of Hb D-Ouled Rabah [beta19(B1)Asn>Lys] in the Turkish population
Figure 2. DNA sequencing of the Hb AX (AAM> M: A/C)
First observation of homozygote Hb Q-Iran (alpha 75 (EF4) Asp-His)
Figure 1. Sequencing data of Hb Q-Iran
Molecular identification of a rare hemoglobin variant, Hb J-Iran [beta77(EF1)His->Asp], in Denizli province of Turkey
Figure 1. Hemoglobin electrophoresis of Hb AX. (O : Origin of application)
Compound heterozygosity for two beta chain variants: the mildly unstable Hb Tyne (codon 5 Pro›Ser) and HbS (codon 6 Glu›Val)
Figure 1. Direct DNA sequence analysis of the mutated strand of a beta-globin gene PCR fragment from the compound heterozygous for Hb Tyne and HbS proband. The normal sequence is shown on the left, and the mutated sequence on the right. The base where substitution of cytosine (C) for tymidine (T) in codon 5 are indicted by a asterisk (*).
Hemoglobin LeporeBoston in a Turkish Family
Figure 1. Hemoglobin electrophoresis; 1. The patient, Lepore trait; 2. Brother; 3. Normal; 4. Father.
1
2
Next Page >
Last Page >>
Sayfa 1 / 2 -- Toplam Kayıt 11 -- Listelenen kayıt sayısı 10
Not null!
Search term(s) must be at least 3 characters!
All Columns
Referance Numbers
Titles
Summeries
Keywords
0 records found...
1
Sayfa 1 / 1 -- Toplam Kayıt 0 -- Listelenen kayıt sayısı 0
AUTOIMMUNE DISORDERS (0 / 0)
Autoimmune Hemolytic Anemias (0 / 0)
Others (0 / 0)
CHEMOKINES (0 / 8)
Chemokines and cytokines (0 / 0)
Chemotactic Effects (0 / 2)
Other Effects (0 / 0)
Hematopoietic (0 / 0)
Angiogenic (0 / 0)
HIV Effects (0 / 6)
Regulation of Receptor Expression (0 / 0)
Signal Transduction (0 / 0)
CYTOGENETICS (0 / 2)
Gene Polymorphisms (0 / 2)
HEMOSTASIS (0 / 87)
Platelet and the vessel wall (0 / 13)
Blood coagulation (0 / 24)
Biology of hemostatic proteins (0 / 4)
Fibrinogen (0 / 0)
Vitamin K-dependent coagulation factors (0 / 0)
Coagulation factors (0 / 4)
Factor VIII-Factor IX-Factor XI (0 / 8)
Other coagulation factors (0 / 0)
Protein C anticoagulant pathway (0 / 0)
Other coagulation inhibitors (0 / 0)
Fibrinolytic enzymes and inhibitors (0 / 0)
Thrombotic Disorders (0 / 36)
Inherited coagulopathies (0 / 4)
Antithrombin deficiency (0 / 0)
Protein C deficiency (0 / 4)
Protein S deficiency (0 / 0)
Factor V Leiden mutation (0 / 0)
Prothrombin t20210A Mutation (0 / 0)
Acquired coagulation disorders (0 / 5)
Disseminated intravascular coagulation (0 / 5)
Liver Disease (0 / 0)
Vitamin K Deficiency (0 / 0)
Massive Transfusion Coagulapathies (0 / 0)
Acquired Inhibitors of coagulation proteins (0 / 0)
Replacement therapies (0 / 0)
Other therapies (0 / 0)
Cancer and thrombosis (0 / 3)
Antiphospholipid antibody syndrome (0 / 1)
Thrombotic thrombocytopenic purpura (0 / 1)
Heparin-induced thrombocytopenia (0 / 0)
Venous thromboembolism treatment (0 / 0)
Arterial thrombosis (0 / 13)
Antithrombotic therapy (0 / 6)
Heparin, low molecular weight heparin (0 / 3)
Direct thrombin inhibitors (0 / 0)
Oral anticoagulants (0 / 3)
Antifibrinolytic therapy (0 / 0)
Endothelium (0 / 1)
HEMATOLOGİC MANIFESTATİONS OF SYSTEMİC DISEASES (0 / 46)
GENE THERAPY (0 / 0)
HEMATOPOIESIS (0 / 8)
Stem and Primitive Progenitor Cells (0 / 0)
Red Blood Cells (0 / 0)
Granulocytes (0 / 1)
Lymphocytes (0 / 3)
Monocytes (0 / 0)
Eosinophilia (0 / 1)
Basophilia (0 / 0)
Megakaryocytes (0 / 3)
Mast Cells (0 / 0)
IRON (0 / 13)
Iron Deficiency (0 / 10)
Iron Overload (0 / 3)
IMMUNOLOGY (0 / 22)
Innate Immunity (0 / 0)
Immunoglobulins (0 / 16)
Antigen Recognition by T Lymphocytes (0 / 0)
The Development of B Lymphocytes (0 / 0)
T-Cell Mediated Immunity (0 / 0)
The Humoral Immune Response (0 / 0)
Immundeficiency dieases (0 / 0)
Allergy and Hypersensitivity (0 / 3)
Immune Response Disorder (0 / 3)
Autoimmunity: responses to self antigens (0 / 2)
Transplant rejection: responses to alloantigens (0 / 0)
Tumor immunology (0 / 0)
Lymphoid Cells Neoplasms (0 / 0)
B-cell neoplasms (0 / 0)
T-cell neoplasms (0 / 0)
NK cell neoplasms (0 / 0)
Others (0 / 0)
INFECTION (0 / 16)
Febril Neutropenia (0 / 6)
Viral Infections (0 / 1)
Fungan Infections (0 / 1)
Bacterial Infections (0 / 2)
Parasitic Infections (0 / 2)
MARROW (0 / 9)
Physiology of Hematopoiesis (0 / 5)
Bone Marrow Failure (0 / 1)
Acquired Aplastic Anemia (0 / 3)
Fanconi Anemia (0 / 0)
Inherited Pure Red Cell Anemia (0 / 0)
Acquired Pure Red Cell Anemia (0 / 0)
STEM CELL TRANSPLANTATION (0 / 54)
Stem cell physiology (0 / 9)
Stem cell mobilization (0 / 0)
Immunologic tolerance (0 / 0)
Graft rejection (0 / 0)
Conditioning regimen (0 / 0)
Allo transplantation (0 / 18)
Auto transplantation (0 / 2)
Non myeloablative (0 / 0)
Organ Specific Toxicity (0 / 3)
Clinical Care of Graft-Versus-Host Disease (0 / 10)
Acute GVHD (0 / 0)
Chronic GVHD (0 / 10)
NEOPLASIA (0 / 354)
Pediatric hematologic Malignancies (0 / 3)
Pediatric Leukemia (0 / 8)
Pediatric Lymphomas (0 / 2)
Acute Leukemia (0 / 12)
Acute Lymphoblastic Leukemia (0 / 36)
Acute Myeloblastic Leukemia (0 / 66)
Myelodysplastic Syndromes (0 / 3)
Chronic Leukemia (0 / 0)
Chronic Lymphocytic Leukemia (0 / 7)
Chronic Myeloid Leukemia (0 / 18)
Other Lymphoproliferative Disorders (0 / 2)
Other Leukemias (0 / 12)
Lymphomas (0 / 37)
Hodgkin Lymphoma (0 / 10)
Non Hodgkin Lymphoma (0 / 45)
Chronic Myeloproliferative Neoplasms (0 / 32)
Pharmacotherapeutics (0 / 3)
Oncogenes (0 / 0)
Multipl myeloma (0 / 45)
Plasmacytoma (0 / 2)
Cryoglobulinemia (0 / 2)
Plasma Cell Disorders (0 / 7)
PHAGOCYTES (0 / 16)
Neutrophils (0 / 4)
Monocytes and Macrophages (0 / 3)
Eosinophils (0 / 3)
Basophils (0 / 0)
Mast cells (0 / 0)
Dendritic cells (0 / 6)
Chemotaxis (0 / 0)
Antigen presentation (0 / 0)
Phagocytosis, cytotoxicity (0 / 2)
PLATELETS (0 / 34)
Physiology of Normal Platelets (0 / 10)
Signal Transduction (0 / 0)
Disorders of Platelets (0 / 12)
von Willebrand Disease (0 / 7)
Acquired Platelet Disorders (0 / 0)
Autoimmune and Alloimmune platelet disorders (0 / 2)
RED CELLS (2 / 92)
Hemoglobin disorders (0 / 6)
Anemia (2 / 40)
Nutritional anemia (0 / 9)
iron, cobalamin, folate deficiency (0 / 7)
Fanconi Anemia (0 / 1)
Aplastic Anemia (0 / 6)
Myeloproliferative and myelodysplasia (0 / 0)
Immune Hemolytic anemias (2 / 12)
Red cell membrane disorders (0 / 7)
Paroxymal Nocturnal hemoglobin (PNH) (0 / 0)
Enzyme disorders (0 / 0)
Sickle cell anemia (0 / 4)
Thalassemia (0 / 19)
Other hemoglobinopathies (0 / 11)
Polycythemia (0 / 4)
Polycythemia Vera (0 / 3)
Secondary Polycythemia (0 / 0)
WHITE CELLS (0 / 4)
Congenital Neutropenia (0 / 3)
Acquired Neutropenia (0 / 0)
Leucocyte Function Disorders (0 / 0)
Lymphocytes (0 / 0)
SUPPORTIVE CARE (0 / 0)
MOLECULAR HEMATOLOGY (0 / 6)
TRANSFUSION MEDICINE (0 / 10)
Apheresis (0 / 4)
Red Blood Cells (0 / 3)
White cell transfusions (0 / 1)
Platelet transfusions (0 / 0)
VASCULAR BIOLOGY (0 / 0)
OTHER (325 / 85)
FLOW CYTOMETRY (0 / 2)
STORAGE DISORDERS (0 / 14)
Spleen (0 / 1)
Experimental Hematology (0 / 3)
IRRADIATION (0 / 3)
Copyright © 2024 Atlas of Hematology. All rights reserved.
LookUs
&
OnlineMakale